These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3388151)

  • 1. Diltiazem compared with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension.
    Leary WP; van der Byl K
    S Afr Med J; 1988 Jul; 74(1):13-5. PubMed ID: 3388151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
    Pool PE; Applegate WB; Woehler T; Sandall P; Cady WJ
    Pharmacotherapy; 1993; 13(5):487-93. PubMed ID: 8247917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
    Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
    J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
    Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
    J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
    Manning G; Joy A; Mathias CJ; McDonald CJ; Millar-Craig MW
    J Hum Hypertens; 1996 Jul; 10(7):443-8. PubMed ID: 8880557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
    Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
    Burris JF; Weir MR; Oparil S; Weber M; Cady WJ; Stewart WH
    JAMA; 1990 Mar; 263(11):1507-12. PubMed ID: 2407872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension.
    Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D
    Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.
    Creisson C; Baulac L; Lenfant B
    Postgrad Med J; 1986; 62 Suppl 1():139-41. PubMed ID: 3534849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
    Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
    Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
    Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
    Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertension.
    Moser M; Lunn J; Materson BJ
    Am J Cardiol; 1985 Dec; 56(16):101H-104H. PubMed ID: 4072939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
    Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
    Nikkilä M; Inkovaara J; Heikkinen J
    Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
    Frishman WH; Goldberger J; Sherman D
    J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily treatment of essential hypertension with captopril.
    Schoenberger JA; Wilson DJ
    J Clin Hypertens; 1986 Dec; 2(4):379-87. PubMed ID: 3543231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.